|
|
|
|
|
|
|
|
Share FOR IMMEDIATE RELEASE PremierStocks.tv (PMSI) announces its latest Stock Alert - Breaking News from Manhattan Scientifics (OTCBB: MHTX) Promotes a New Technology to Eliminate False Positive Cancer Analysis |
|
MESA, AZ, July 29, 2010, --/WORLD-WIRE/-- PremierStocks.tv (PMSI) is following the Manhattan Scientifics (OTCBB: MHTX) after a New York Times article highlights the potential value of the early cancer detection technology developed by Senior Scientific, LLC and licensed by Manhattan Scientifics. For more information about Manhattan Scientifics, Inc. Investors can visit www.PremierStocks.tv or MHTX.com Manhattan Scientifics Promoting a New Technology to Eliminate False Positive Cancer Analysis New Technology Holds Promise for Zero-Error Cancer Pathology Present-day "Flip of the Coin" Treatment Decisions Described in NY Times Due to outright error and case-by-case disagreement, biopsy diagnosis often leads to unnecessary surgery ALBUQUERQUE, N.M.- Thursday, July 29, 2010 - Manhattan Scientifics, Inc. (OTCBB: MHTX) said today that a July 20th New York Times article titled "Prone to Error: Earliest Steps to Find Cancer" highlights the potential value of the early cancer detection technology developed by Senior Scientific, LLC and licensed by Manhattan Scientifics. The story focused on widespread problems associated with incorrect diagnosis of breast cancer, and cited one study in which 90,000 women either did not have the disease or their pathologist made an error that resulted in incorrect treatment. Earlier this year Manhattan Scientifics announced that it had acquired exclusive rights to commercialize the early cancer detection technology developed by Senior Scientific, LLC, and a team of scientists led by Edward R. Flynn, Ph.D. The non-radiation diagnostic technology, which is in the early stages of testing, uses cancer-seeking nanotechnology. Magnetic, nano-sized cancer-targeting antibodies which bind only to cancer cells are employed, and are capable of detecting a cancerous breast tumor with only 100,000 malignant cells. The current gold-standard Mammogram requires 100 million malignant cells before a tumor can be detected. The new experimental technology is 1,000 times more sensitive and capable of detecting breast cancers 3 years earlier than with Mammograms. In an attempt to identify an appropriate industrial partner to help move the technology from "Bench to Bedside", Manhattan Scientifics is screening the medical device and biotechnology industries, and has entered into discussions with former senior management of the FDA in an effort to accelerate the process to bring product to the market. In addition to the www.mhtx.com website, management is pleased to announce the addition of a website dedicated exclusively to the Senior Scientific LLC technology which can be accessed at www.seniorscientific.com. Manhattan's CEO Manny Tsoupanarias said, "The technology is designed to eliminate false positives. Thus far, the cancer tests have produced objective, not subjective, results. The system is able to selectively detect cancers during their earliest state of growth, years before current detection systems." He continued, "We have a long way to go, but every journey begins with the first steps, and we are moving forward quickly." Mr. Tsoupanarias continued, "We are cash-flow positive now and we've already demonstrated our ability to "partner" with Fortune/ 1000 companies to bring nano-medicine products to market. This story in the New York Times underscores the importance of Senior Scientifics' technology which holds the potential to alter the diagnostic approach to a variety of cancers including: Breast, Ovarian, Pancreatic, Skin, Cervical, Brain (glioblastoma), Prostate, Colon, Bladder and other forms of cancer." Senior Scientific is a pioneering company in the emerging field of nanomedicine. The company has been supported for eight years by nine grants from the National Institutes of Health and a grant from the U.S. Department of Defense. The technology is protected by issued and pending patents. About Manhattan Scientifics Manhattan Scientifics, Inc., (OTCBB: MHTX), is a leading information age enterprise focused on the nanomedicine space. Located in New Mexico, New York and Montreal, Manhattan Scientifics' goal is to create profit for the company's shareholders through royalty-bearing licenses with Fortune 1000 companies by marketing products that rely on the company's patents, know-how and intellectual property. Manhattan Scientifics owns the exclusive, perpetual U.S. license to a family of patents which will enable the manufacture and marketing of super strong, ultra light-weight "nanostructured" metals that have been developed at the Los Alamos National Laboratory (LANL) and in the former Soviet Union. More information about Manhattan Scientifics can be found at www.mhtx.com and at www.seniorscientific.com Forward looking statement: Certain statements contained in this press release are "forward looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected and are not guarantees of future performance. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Manhattan Scientifics assumes no obligation and does not intend to update these forward-looking statements. Manhattan Scientifics, Inc. Marvin Maslow, Director of Investor Relations, 917-923-3300 marvin@mhtx.com or European Investor Relations: Herbert Strauss, +43-316-296-316 herbert@eu-ir.com or U.S. & Canadian Investor Relations: Hawk Associates Frank Hawkins, 305-451-1888 f.hawkins@hawkassociates.com Release of Liability: Through use of our website, Email Alerts, and stock alerts viewing or using, you agree to hold PremierStocks.tv, Premier Media Services, Inc., its operators, shareholders, consultants, associates and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. PremierStocks.tv and Premier Media Services, Inc. affiliates and associates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Premier Media Services, Inc. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and PremierStocks.tv makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. PremierStocks.tv - Your financial news at your finger tips - Don't forget to tune into our weekly financial shows, were we discuss Wall Street Stocks, Finance, Security and Exchange Commission, Oil, Gas, Apple, Gadgets, Business, News, how-to, investing, investments, and The Good, The Bad and The Ugly of Wall Street! CONTACT: Kelly Black, President Premier Media Services, Inc. Tel: 480-649-8224 Kblack@premiermediaservice.com www.PremierStocks.tv |
|
|